#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA1681172	Functional	Antimicrobial activity against Cryptosporidium parvum infected in human HCT-8 cells after 48 hrs by ELISA	Cryptosporidium parvum	3	ALA1671619	organism-based format	Scientific Literature
2.	ALA1681173	ADME	Cytotoxicity against human HCT8 cells assessed as reduction in viable cells after 48 hrs by MTS assay	Homo sapiens	1	ALA1671619	cell-based format	Scientific Literature
3.	ALA1681174	ADME	Cytotoxicity against human HCT8 cells assessed as reduction in viable cells after 48 hrs at 1.6 uM by MTS assay	Homo sapiens	1	ALA1671619	cell-based format	Scientific Literature
4.	ALA1673848	Functional	Antimicrobial activity against Cryptosporidium parvum infected in neonatal BALB/C mouse assessed as reduction in oocyst shedding at 5 mg/kg/day, po for 4 days treated 3 days postinfection	Cryptosporidium parvum	1	ALA1671619	organism-based format	Scientific Literature
5.	ALA1673850	Functional	Antimicrobial activity against Cryptosporidium parvum infected in neonatal BALB/C mouse assessed as reduction in oocyst shedding at 12.5 mg/kg/day, po for 4 days treated 3 days postinfection	Cryptosporidium parvum	1	ALA1671619	organism-based format	Scientific Literature
6.	ALA1673851	Functional	Antimicrobial activity against Cryptosporidium parvum infected in neonatal BALB/C mouse assessed as reduction in oocyst shedding at 5 mg/kg/day, po for 6 days treated 3 days postinfection	Cryptosporidium parvum	1	ALA1671619	organism-based format	Scientific Literature
7.	ALA1673853	Functional	Antimicrobial activity against Cryptosporidium parvum infected in neonatal BALB/C mouse assessed as reduction in trophozoites in ileum at 5 mg/kg/day, po for 6 days by hematoxylin and eosin staining	Cryptosporidium parvum	1	ALA1671619	organism-based format	Scientific Literature
8.	ALA1673854	Functional	Antimicrobial activity against Cryptosporidium parvum infected in neonatal BALB/C mouse assessed as reduction in trophozoites in appendix at 5 mg/kg/day, po for 6 days by hematoxylin and eosin staining	Cryptosporidium parvum	1	ALA1671619	organism-based format	Scientific Literature
9.	ALA1673855	Functional	Antimicrobial activity against Cryptosporidium parvum infected in neonatal BALB/C mouse assessed as reduction in trophozoites in colon at 5 mg/kg/day, po for 6 days by hematoxylin and eosin staining	Cryptosporidium parvum	1	ALA1671619	organism-based format	Scientific Literature
10.	ALA1673867	Functional	Antimicrobial activity against Cryptosporidium parvum infected in neonatal BALB/C mouse assessed as reduction in number of trophozoites at 5 mg/kg/day, po for 6 days	Cryptosporidium parvum	1	ALA1671619	organism-based format	Scientific Literature
11.	ALA4373434	Binding	Inhibition of Wnt3a activated Wnt/beta-catenin signaling (unknown origin) expressed in HEK293 cells harboring TCF/LEF-responsive luciferase preincubated with cells followed by Wnt3a addition and measured after 24 hrs by luciferase reporter gene assay	Homo sapiens	22	ALA4371095	cell-based format	Scientific Literature
12.	ALA4373469	ADME	Oral bioavailability in mouse	Mus musculus	1	ALA4371095	organism-based format	Scientific Literature
13.	ALA4417242	Binding	Inhibition of Wnt/beta-Catenin signaling (unknown origin) expressed in recombinant human Wnt-3a-induced Wnt-HEK293 cells incubated for 24 hrs by luciferase reporter gene assay	Homo sapiens	26	ALA4414663	cell-based format	Scientific Literature
14.	ALA4417246	Functional	Growth inhibition of human SW480 cells by Cell-titer-fluor reagent based assay	Homo sapiens	11	ALA4414663	cell-based format	Scientific Literature
15.	ALA4417247	Binding	Inhibition of Wnt/beta-Catenin signaling (unknown origin) expressed in recombinant human Wnt-3a-induced Wnt-HEK293 cells assessed as increase in beta-catenin degradation at 1 uM by Western blot analysis	Homo sapiens	3	ALA4414663	cell-based format	Scientific Literature
16.	ALA4418847	Binding	Inhibition of His-tagged human recombinant SHMT2 expressed in Escherichia coli BLR(DE3) assessed as reduction in NADPH level using L-serine, THF and NADP+ at 6.5 or 26.5 uM incubated for 5 mins by SHMT2-MTHFD coupled reaction based fluorescence assay relative to control	Homo sapiens	46	ALA4418497	assay format	Patent Bioactivity Data
17.	ALA4418848	Binding	Inhibition of His-tagged human recombinant SHMT2 expressed in Escherichia coli BLR(DE3) assessed as reduction in NADPH level using L-serine, THF and NADP+ incubated for 5 mins by SHMT2-MTHFD coupled reaction based fluorescence assay	Homo sapiens	195	ALA4418497	assay format	Patent Bioactivity Data
18.	ALA4420451	Binding	Inhibition of C-Myc/DDK-tagged human recombinant SYNJ2 expressed in HEK293T cells assessed as reduction in 5'-phosphatase activity incubated for 8 mins using fluorescently-labeled PI(3,4)P2 probe and Tapp1 PH-domain as detector protein by fluorescence polarization competitive assay	Homo sapiens	24	ALA4420065	cell-based format	Patent Bioactivity Data
19.	ALA4420452	Binding	Inhibition of C-Myc/DDK-tagged human recombinant SYNJ1 expressed in HEK293T cells assessed as reduction in 5'-phosphatase activity incubated for 8 mins using fluorescently-labeled PI(3,4)P2 probe and Tapp1 PH-domain as detector protein by fluorescence polarization competitive assay	Homo sapiens	24	ALA4420065	cell-based format	Patent Bioactivity Data
20.	ALA4420453	Binding	Binding affinity to C-Myc/DDK-tagged human recombinant SYNJ2 expressed in HEK293T cells by microscale thermophoresis assay	Homo sapiens	1	ALA4420065	cell-based format	Patent Bioactivity Data